{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:41:29Z","timestamp":1788903689063,"version":"build-2803163510"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Lymphopenia induced by radiotherapy or chemotherapy can promote homeostatic proliferation of residual or adoptive lymphocytes, potentially enhancing antitumor immunity. However, this immunity diminishes rapidly with tumor progression, and the underlying mechanisms remain unclear. This study investigates the role of PD-1 signaling in homeostatic proliferation\u2013induced antitumor immunity in malignant melanoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We evaluated T-cell dynamics in lymphopenic mice, analyzing PD-1 expression, IFN-\u03b3 production by CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells, and T-cell cytotoxicity during homeostatic proliferation. The PD-1\/PD-L1 axis was blocked using anti-PD-1 antibodies to assess its impact on T-cell function, dendritic cell (DC) activation, and memory T-cell differentiation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Although T cells proliferated continuously in lymphopenic mice, IFN-\u03b3+ CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells declined over time. PD-1 expression on T cells increased progressively and correlated negatively with effector T-cell cytotoxicity. PD-1 blockade enhanced the recognition of tumor-associated antigens (TAAs) by homeostatically proliferating (HP) T cells, activated DCs, and increased IFN-\u03b3+ CD8+ T-cell numbers. Additionally, it boosted T-cell cytotoxicity and promoted the conversion of tumor-specific effector T cells into central memory T cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These findings indicate that the PD-1\/PD-L1 axis plays a critical role in immune tolerance during homeostatic proliferation. Anti-PD-1 therapy may enhance antitumor immunity during lymphopenia recovery after chemotherapy or radiotherapy, offering a potential strategy to sustain T-cell\u2013mediated tumor control.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1563894","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T07:47:37Z","timestamp":1746172057000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Anti-PD-1 antibody enhances homeostatic proliferation\u2013induced antitumor immunity during lymphopenia recovery"],"prefix":"10.3389","volume":"16","author":[{"given":"Zike","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00982-7","article-title":"New immune cell engagers for cancer immunotherapy","volume":"24","author":"Fenis","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1038\/s41467-024-46448-9","article-title":"Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus","volume":"15","author":"Doglio","year":"2024","journal-title":"Nat Commun"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0801829","article-title":"Recovery from cyclophosphamide-induced lymphopenia results in expansion of immature dendritic cells which can mediate enhanced prime-boost vaccination antitumor responses in vivo when stimulated with the TLR3 agonist poly(I:C)","volume":"182","author":"Salem","year":"2009","journal-title":"J Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0215175","article-title":"T cell homeostatic proliferation elicits effective antitumor autoimmunity","volume":"110","author":"Dummer","year":"2002","journal-title":"J Clin Invest"},{"key":"B5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13014-017-0824-x","article-title":"Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma[J","volume":"12","author":"Liu","year":"2017","journal-title":"Radiat Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1209","article-title":"Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration","volume":"13","author":"Bracci","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.ccell.2024.08.019","article-title":"Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stabl e colorectal cancer","volume":"42","author":"Wang","year":"2024","journal-title":"Cancer Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01961-3","article-title":"Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral contro","volume":"25","author":"Weiss","year":"2024","journal-title":"Nat Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-016-0968-y","article-title":"Anti-PD-L1\/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application","volume":"21","author":"Mandai","year":"2016","journal-title":"Int J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2016.06.006","article-title":"Association of programmed death-1 polymorphisms with the risk and prognosis of esophageal squamous cell carcinoma","volume":"209","author":"Zhou","year":"2016","journal-title":"Cancer Genet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-013-1503-x","article-title":"Programmed death ligand-1 over-expression correlates with Malignancy and contributes to immune regulation in ovarian cancer","volume":"63","author":"Maine","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2018.10.025","article-title":"PD-1 immunobiology in systemic lupus erythematosus","volume":"97","author":"Curran","year":"2019","journal-title":"J Autoimmun"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03061","article-title":"Regulation of GVHD and GVL activity via PD-L1 interaction with PD-1 and CD80","volume":"9","author":"Cassady","year":"2018","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.imlet.2022.09.004","article-title":"Lymphopenic condition enhanced the antitumor immunity of PD-1-knockout T cells mediated by CRISPR\/Cas9 system in Malignant melanoma","volume":"250","author":"Yang","year":"2022","journal-title":"Immunol Lett"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01289","article-title":"PD-1 controls tonic signaling and lymphopenia-induced proliferation of T lymphocytes","author":"Ellestad","year":"2017","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-206870","article-title":"Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment","volume":"114","author":"Lee","year":"2009","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.06.020","article-title":"Radiation therapy to convert the tumor into an in situ vaccine","volume":"84","author":"Formenti","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-411124","article-title":"Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia","volume":"120","author":"Baba","year":"2012","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3390\/life11030245","article-title":"Regulatory T cells fail to suppress fast homeostatic proliferation in vitro","volume":"11","author":"Shevyrev","year":"2021","journal-title":"Life (Basel)."},{"key":"B20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-024-01581-2","article-title":"Dual blockade immunotherapy targeting PD-1\/PD-L1 and CTLA-4 in lung cancer","volume":"17","author":"Cheng","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2015.07.003","article-title":"Reorienting the immune system in the treatment of cancer by using anti-PD-1 and anti-PD-L1 antibodies","volume":"20","author":"Borch","year":"2015","journal-title":"Drug Discov Today"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1563894\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T07:47:38Z","timestamp":1746172058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1563894\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":22,"alternative-id":["10.3389\/fimmu.2025.1563894"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1563894","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"article-number":"1563894"}}